trial · primary record
SYS6055
Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 384 |
| Primary completion | 2031-12-15 |
| Primary endpoint | Dose-limiting toxicities (DLTs) |
| Registry ID | NCT07905261 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:55.467Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07905261
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.